Antioxidative status of patients with alcoholic liver disease in southeastern Taiwan

doi:10.3748/wjg.v17.i8.1063

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 8

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2201)

All Articles published online

The chart showing PDF series, HTML series, Tables (1-6) series.

Item

Count

PDF

269

HTML

1661

Tables (1-6)

271

Sum=2201

Feb 28, 2011 (publication date) through Feb 11, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Feb 28, 2011; 17(8): 1063-1070
Published online Feb 28, 2011. doi: 10.3748/wjg.v17.i8.1063

Table 1 Biochemical parameters of control subjects and patients with alcoholic liver disease (mean ± SE)

	Control	ALD
n	22	27
Male/female	19/3	23/4
Age (yr)	41.2 ± 2.1	45.3 ± 2.1
Height (cm)	169.7 ± 1.2	165.3 ± 1.3^a
Weight (kg)	66.1 ± 1.8	65.4 ± 2.3
BMI (kg/m²)	23.9 ± 0.6	23.9 ± 0.8
AST (U/L)	20.7 ± 0.9	63.6 ± 8.7^a
ALT (U/L)	22.6 ± 1.7	39.1 ± 5.2^a
AST/ALT	1.0 ± 0.06	2.86 ± 0.86^a
γ-GT (U/L)	29.2 ± 3.5	271.1 ± 81.3^a
TC (mg/dL)	185.6 ± 5.5	153.7 ± 13.2^a
TG (mg/dL)	99.4 ± 13.2	193.6 ± 61.2
HDL-C (mg/dL)	50.5 ± 3.1	36.7 ± 2.6^a
LDL-C (mg/dL)	125.5 ± 6.8	72 ± 8.2^a
Albumin (gm/dL)	4.75 ± 0.06	3.33 ± 0.18^a
Uric acid (mg/dL)	6.26 ± 0.29	6.81 ± 0.45
Total bilirubin	0.56 ± 0.04	5.53 ± 2.21^a

^aP < 0.05 vs the control group (by Student’s t-test). ALD: Alcoholic liver disease; BMI: Body-mass index; AST: Aspartate aminotransferase; ALT: Alanine transaminase; γ-GT: γ-glutamyltransferase; TC: Total cholesterol; TG: Triglycerides; HDL-C: High-density lipoprotein-cholesterol; LDL-C: Low-density lipoprotein-cholesterol.

Table 2 Erythrocytic antioxidative enzymes activities, erythrocytic reduced glutathione/oxidized glutathione ratio and plasma thiobarbituric acid reactive substances concentration of control subjects and patients with alcoholic liver disease (mean ± SE)

	Control	ALD
GPX (U/g Hb)	27.9 ± 2.2	34.4 ± 4.2
GRD (U/g Hb)	0.55 ± 0.06	0.62 ± 0.05
CAT (U/mg Hb)	11.1 ± 0.7	8.0 ± 0.7^a
SOD (U/mg Hb)	9.5 ± 1.6	3.0 ± 0.2^a
GSH/GSSG	38.1 ± 5.4	15.7 ± 1.9^a
TBARS (μmol/L)	3.5 ± 0.2	4.1 ± 0.6

^aP < 0.05 vs the control group (by Student’s t-test). ALD: Alcoholic liver disease; GPX: Glutathione peroxidase; GRD: Glutathione reductase; CAT: Catalase; SOD: Superoxide dismutase; GSH: Reduced glutathione; GSSG: Oxidized glutathione; TBARS: Thiobarbituric acid reactive substances.

Table 3 Biochemical parameters of control subjects, and non-aboriginal and aboriginal patients with alcoholic liver disease (mean ± SE)

	Control	Non-aboriginal ALD	Aboriginal ALD
n	22	12	15
Male/female	19/3	12/0	11/4
Age (yr)	41.2 ± 2.1^a	51.3 ± 2.7^b	40.5 ± 2.4^a
Height (cm)	169.7 ± 1.2^a	167.6 ± 1.6^a,b	163.6 ± 1.7^b
Weight (kg)	66.1 ± 1.8^a	66.5 ± 3.7^a	64.5 ± 3.1^a
BMI (kg/m²)	23 ± 0.6^a	23.7 ± 1.2^a	24.1 ± 1.1^a
AST (U/L)	20.7 ± 0.9^a	58.0 ± 10.7^b	68.1 ± 13.4^b
ALT (U/L)	22.6 ± 1.8^a	42.8 ± 10.0^b	36.1 ± 5.1^a,b
AST/ALT	1.0 ± 0.1^a	3.0 ± 1.4^a	2.7 ± 1.1^a
γ-GT (U/L)	29.2 ± 3.5^a	335.9 ± 173.4^b	219.3 ± 53.0^a,b
TC (mg/dL)	185.6 ± 5.5^a	157.3 ± 15.8^a	150.6 ± 21.0^a
TG (mg/dL)	99.4 ± 13.2^a	136.4 ± 66.3^a	239.4 ± 109.3^a
HDL-C (mg/dL)	50.5 ± 3.1^a	39.8 ± 4.5^b	34.3 ± 3.1^b
LDL-C (mg/dL)	125.5 ± 6.8^a	88.8 ± 13.4^b	58.5 ± 9.2^c
Albumin (gm/dL)	4.75 ± 0.06^a	3.68 ± 0.23^b	2.93 ± 0.25^c
Uric acid (mg/dL)	6.26 ± 0.29^a	6.74 ± 0.45^a	6.89 ± 0.89^a
Total bilirubin	0.56 ± 0.04^a	3.74 ± 1.43^a,b	7.31 ± 4.23^b

Values in the same row with different letters (a, b, c) significantly different at P < 0.05 (by one-way analysis of variance). ALD: Alcoholic liver disease; BMI: Body-mass index; AST: Aspartate aminotransferase; ALT: Alanine transaminase; γ-GT: γ-glutamyltransferase; TC: Total cholesterol; TG: Triglycerides; HDL-C: High-density lipoprotein-cholesterol; LDL-C: Low-density lipoprotein-cholesterol.

Table 4 Erythrocytic antioxidative enzymes activities, erythrocytic reduced glutathione/oxidized glutathione ratio and plasma thiobarbituric acid reactive substances concentration of control subjects, and non-aboriginal and aboriginal patients with alcoholic liver disease (mean ± SE)

	Control	Non-aboriginal ALD	Aboriginal ALD
GPX (U/g Hb)	27.9 ± 2.2^a	46.1 ± 7.8^b	25.0 ± 0.2^a
GRD (U/g Hb)	0.55 ± 0.06^a	0.68 ± 0.07^a	0.58 ± 0.07^a
CAT (U/mg Hb)	11.1 ± 0.7	8.5 ± 0.9^b	7.6 ± 1.1^b
SOD (U/mg Hb)	9.5 ± 1.6^a	2.9 ± 0.3^b	3.1 ± 0.3^b
GSH/GSSG	38.0 ± 5.4^a	16.5 ± 3.8^b	15.0 ± 1.6^b
TBARS (μmol/L)	3.5 ± 0.2^a	3.4 ± 0.5^a	4.6 ± 1.0^a

Values in the same row with different letters (a, b) significantly different at P < 0.05. (by one-way analysis of variance). ALD: Alcoholic liver disease; GPX: Glutathione peroxidase; GRD: Glutathione reductase; CAT: Catalase; SOD: Superoxide dismutase; GSH: Reduced glutathione; GSSG: Oxidized glutathione; TBARS: Thiobarbituric acid reactive substances.

Table 5 Biochemical parameters of control subjects, and patients with hepatitis and cirrhosis alcoholic liver disease (mean ± SE)

	Control	Hepatitis ALD	Cirrhosis ALD
n	22	10	17
Male/female	19/3	9/1	14/3
Age (yr)	41.2 ± 2.1^a	45.4 ± 4.2^a	45.3 ± 2.2^a
Height (cm)	169.7 ± 1.2^a	167.4 ± 2.3^a,b	164.2 ± 1.5^b
Weight (kg)	66.1 ± 1.8^a	70.4 ± 3.4^a	62.6 ± 3.0^a
BMI (kg/m²)	23.0 ± 0.6^a	25.2 ± 1.3^a	23.2 ± 1.0^a
AST (U/L)	20.7 ± 0.9^a	66.9 ± 18.6^b	61.7 ± 9.1^b
ALT (U/L)	22.6 ± 1.8^a	46.2 ± 12.7^b	34.9 ± 3.8^a,b
AST/ALT	1.0 ± 0.06^a	4.49 ± 2.28^b	1.9 ± 0.22^a,b
γ-GT (U/L)	29.2 ± 3.5^a	207.8 ± 71.7^a,b	308.4 ± 123.1^b
TC (mg/dL)	185.6 ± 5.5^a	188.9 ± 26.2^a	131.8 ± 11.5^b
TG (mg/dL)	99.4 ± 13.2^a	293.5 ± 153.5^b	134.9 ± 35.8^a,b
HDL-C (mg/dL)	50.5 ± 3.1^a	45.1 ± 3.8^a	31.8 ± 3.0^b
LDL-C (mg/dL)	125.5 ± 6.8^a	94.4 ± 15.8^b	58.8 ± 8.0^c
Albumin (gm/dL)	4.75 ± 0.06^a	3.87 ± 0.38^b	3.08 ± 0.17^c
Uric acid (mg/dL)	6.26 ± 0.29^a	6.68 ± 0.71^a	6.86 ± 0.59^a
Total bilirubin	0.56 ± 0.04^a	1.22 ± 0.17^a	7.48 ± 3.06^b

Values in the same row with different letters (a, b, c) significantly differ at P < 0.05. (by one-way analysis of variance). ALD: Alcoholic liver disease; BMI: Body-mass index; AST: Aspartate aminotransferase; ALT: Alanine transaminase; γ-GT: γ-glutamyltransferase; TC: Total cholesterol; TG: Triglycerides; HDL-C: High-density lipoprotein-cholesterol; LDL-C: Low-density lipoprotein-cholesterol.

Table 6 Erythrocytic antioxidative enzyme activities, erythrocytic reduced glutathione/oxidized glutathione ratio and plasma thiobarbituric acid reactive substances concentration of control subjects, patients with hepatitis and cirrhosis alcoholic liver disease (mean ± SE)

	Control	Hepatitis ALD	Cirrhosis ALD
GPX (U/g Hb)	27.9 ± 2.2^a	44.3 ± 8.6^b	28.5 ± 3.8^a
GRD (U/g Hb)	0.55 ± 0.06^a	0.74 ± 0.06^a	0.56 ± 0.07^a
CAT (U/mg Hb)	11.1 ± 0.7^a	10.8 ± 1.2^a	6.4 ± 0.6^b
SOD (U/mg Hb)	9.5 ± 1.6^a	3.7 ± 0.2^b	2.6 ± 0.2^b
GSH/GSSG	38.1 ± 5.4^a	18.3 ± 4.2^b	14.2 ± 1.7^b
TBARS (μmol/L)	3.5 ± 0.2^a	4.2 ± 1.1^a	4.0 ± 0.7^a

Values in the same row with different letters (a, b) significantly different at P < 0.05 (by one-way analysis of variance). ALD: Alcoholic liver disease; GPX: Glutathione peroxidase; GRD: Glutathione reductase; CAT: Catalase; SOD: Superoxide dismutase; GSH: Reduced glutathione; GSSG: Oxidized glutathione; TBARS: Thiobarbituric acid reactive substances.

Citation: Chen YL, Chen LJ, Bair MJ, Yao ML, Peng HC, Yang SS, Yang SC. Antioxidative status of patients with alcoholic liver disease in southeastern Taiwan. World J Gastroenterol 2011; 17(8): 1063-1070
URL: https://www.wjgnet.com/1007-9327/full/v17/i8/1063.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i8.1063